maltofer syrup 50mg5ml
vifor pharma asia pacific pte. ltd. - hydroxide polymaltose complex eqv iron - syrup - 10mg/ml - hydroxide polymaltose complex eqv iron 50mg/5ml
maltofer drops 50 mgml
vifor pharma asia pacific pte. ltd. - iron hydroxide polymaltose eqv iron - solution - 50 mg/ml - iron hydroxide polymaltose eqv iron 50 mg/ml
venofer 20 mg iron/ml solution for injection or concentrate for solution for infusion, ampoule
vifor france - iron (iii) - solution for injection/infusion - 20 milligram(s)/millilitre - iron trivalent, oral preparations; saccharated iron oxide
venofer 20 mg iron/ml solution for injection or concentrate for solution for infusion, vial
vifor france - iron (iii) - hydroxide sucrose complex - solution for injection/infusion - 20 milligram(s)/millilitre - iron trivalent, oral preparations; saccharated iron oxide
feraccru
shield tx (uk) limited - ferric maltol - anemia, iron-deficiency - antianemic preparations - feraccru is indicated in adults for the treatment of iron deficiency anaemia (ida) in patients with inflammatory bowel disease (ibd).
feraccru 30mg capsules
shield therapeutics (uk - ferric maltol - capsule - 30mg
eurofer 10mg/ml syrup
osoth inter laboratories co. - iron (iii)-hydroxide polymaltose complex - syrup - 10mg/ml
eurofer syrup
osoth inter laboratories co. - iron (iii)-hydroxide polymaltose complex - syrup - 10mg/ml
medifer syrup
medical horizon llc - iron (iii)-hydroxide and polymaltose complex - syrup - 10mg/ml
doxepin hydrochloride capsule
stat rx usa llc - doxepin hydrochloride (unii: 3u9a0fe9n5) (doxepin - unii:5asj6huz7d) - doxepin hcl is recommended for the treatment of: - psychoneurotic patients with depression and/or anxiety. - depression and/or anxiety associated with alcoholism (not to be taken concomitantly with alcohol). - depression and/or anxiety associated with organic disease (the possibility of drug interaction should be considered if the patient is receiving other drugs concomitantly). - psychotic depressive disorders with associated anxiety including involutional depression and manic-depressive disorders. the target symptoms of psychoneurosis that respond particularly well to doxepin hcl include anxiety, tension, depression, somatic symptoms and concerns, sleep disturbances, guilt, lack of energy, fear, apprehension and worry. clinical experience has shown that doxepin hcl is safe and well tolerated even in the elderly patient. owing to lack of clinical experience in the pediatric population, doxepin hcl is not recommended for use in children under 12 years of age. doxepin hcl is contraindicated in individuals who